{"organizations": [], "uuid": "28729200472dad1f44b68e9c6c743becec826384", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/03/08/the-associated-press-audentes-therapeutics-reports-4q-loss.html", "country": "US", "domain_rank": 767, "title": "Audentes Therapeutics reports 4Q loss", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-08T23:25:00.000+02:00", "replies_count": 0, "uuid": "28729200472dad1f44b68e9c6c743becec826384"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/03/08/the-associated-press-audentes-therapeutics-reports-4q-loss.html", "ord_in_thread": 0, "title": "Audentes Therapeutics reports 4Q loss", "locations": [], "entities": {"persons": [], "locations": [{"name": "san francisco", "sentiment": "none"}], "organizations": [{"name": "audentes therapeutics", "sentiment": "negative"}, {"name": "audentes therapeutics inc.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN FRANCISCO (AP) _ Audentes Therapeutics Inc. (BOLD) on Thursday reported a loss of $24.4 million in its fourth quarter.\nOn a per-share basis, the San Francisco-based company said it had a loss of 82 cents.\nThe results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 92 cents per share.\nFor the year, the company reported that its loss widened to $90.2 million, or $3.40 per share.\nAudentes Therapeutics shares have climbed 5.5 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $32.97, more than doubling in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on BOLD at https://www.zacks.com/ap/BOLD", "external_links": [], "published": "2018-03-08T23:25:00.000+02:00", "crawled": "2018-03-09T09:51:05.002+02:00", "highlightTitle": ""}